Eye On A.I. #291 Naveen Jain: How AI Predicts Cancer, Diabetes & Chronic Illness
Oct 6, 2025
Naveen Jain, a serial entrepreneur and CEO of Viome, discusses his journey into healthcare after a family loss to pancreatic cancer. He reveals how AI and RNA sequencing are being harnessed to predict chronic diseases like cancer and diabetes. Jain explains why RNA is a superior health indicator compared to DNA and describes Viome’s innovative approach to analyzing microbiomes for early disease detection. He emphasizes the potential of asking the right questions to drive innovation and shares insights on personalized health interventions.
AI Snips
Chapters
Transcript
Episode notes
Three Questions Before Starting
- Use the three-question framework: Why this, why now, why me before starting any big project.
- Break problems into solvable modules and map which technologies are emerging to scale them.
Chronic Diseases Evolve Slowly
- Chronic diseases develop slowly over 8–15 years, so early molecular signals should be detectable long before symptoms appear.
- Detecting those early changes makes prevention and reversal plausibly achievable at scale.
RNA Reveals Early Disease Activity
- RNA and gene expression change at disease onset while DNA remains static, so RNA gives earlier, functional signals than DNA.
- Viome prioritized metatranscriptomics to read microbial and human activity rather than DNA presence alone.